Home Business & Economics

Business & Economics

Sutro Biopharma to Receive Milestone Payment from Merck KGaA for Bispecific ADC Candidate

Sutro Biopharma has achieved a milestone under its collaboration and license agreement with the healthcare division of Merck KGaA,...

Comprehensive Service Accelerates Development of ADCs and Reduces Time to Clinic

A new service called ADC Express™services, launched by MilliporeSigma, allows for the rapid production of Antibody-drug Conjugates or ADCs....

Glycotope and Tubulis Sign Agreement for ADC Discovery

Glycotope, a clinical stage biotechnology company, and Tubulis, developing uniquely matched protein drug-conjugates,  have signed a research...

Strategic Alliance Helps the Development Antibody Fragment-Drug Conjugates

In August 2019 Antikor Biopharma and Essex Bio-Technology confirmed that the companies had entered into an investment...
Featured Image: Nyhavn, Copenhagen, Denmark. Courtesy: © Fotolia. Used with permission.

ADCendo Secures Funding to Fill Gap After Market Withdrawal of Olaratumab in STS

ADCendo, a biotechnology spin-out from the University of Copenhagen and the Finsen Laboratory of Rigshospitalet in Copenhagen, Denmark, developing...

AbbVie Discontinues Research and Development Program for Rovalpituzumab Tesirine

MERU, a Phase III trial evaluating rovalpituzumab tesirine (Rova-T / SC16LD6.5; AbbVie) as a first-line maintenance therapy for advanced...
Featured Image: ADC Therapeutics Booth at AACR 2018 Courtesy: © 2017 – 2018. Sunvalley Communication, LLC / Evan Wendt. Used with permission.

Freenome Enters Biomarker Development Collaboration with ADC Therapeutics

Swiss-based ADC Therapeutics, an oncology-drug development company specializes in the development of antibody drug conjugates (ADCs), and Freenome, a...

Araris Biotech Closes Seed Financing to Support Development of Antibody-drug Conjugates

Swiss-based Araris Biotech confirmed the closing of an oversubscribed seed financing round of CHF 2.5 million with participation of...

Kent Payne, Ph.D. and Brandon Price, Ph.D. Join the Board of Directors of Goodwin...

Contract Development and Manufacturing Organization (CDMO) Goodwin Biotechnology, which focuses on process development and cGMP contract manufacturing of monoclonal...
Boston

Conagen Acquires Therapeutic Proteins Production Platform

Boston-based Conagen, a synthetic biology company and a leader in bioengineering, has acquired a fermentation-based technology for the production...

FEATURED RESOURCES